CIPLA
Back to All Ratios
|
CIPLA Last 5 Year Current Ratio History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Current Ratio(x) | 3.70 | 3.34 | 2.99 | 2.87 | 2.66 |
What is the latest Current Ratio ratio of CIPLA ?
Year | Current Ratio |
---|---|
Mar2024 | 3.70 |
Mar2023 | 3.34 |
Mar2022 | 2.99 |
Mar2021 | 2.87 |
Mar2020 | 2.66 |
How is Current Ratio of CIPLA Trending?
Years | Current Ratio | % Change | |
---|---|---|---|
Mar2024 | 3.7 | 10.78 | |
Mar2023 | 3.34 | 11.71 | |
Mar2022 | 2.99 | 4.18 | |
Mar2021 | 2.87 | 7.89 | |
Mar2020 | 2.66 | - |
Other Financial Ratios of CIPLA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Quick Ratio Interest Cover Total Debt/Mcap |
Compare Current Ratio ratio of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹120,033.6 Cr | -0.9% | -1.7% | 17.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,352.0 Cr | 1.7% | -4.7% | 48.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,265.0 Cr | 4.4% | 3.1% | 66% | Stock Analytics | |
MANKIND PHARMA | ₹102,231.0 Cr | -2.1% | -0.6% | 33.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,286.0 Cr | -1% | -8.9% | 6.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,461.4 Cr | -1% | -4% | 48.4% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | -0.9% |
-1.7% |
17.3% |
SENSEX | 1.8% |
-2.5% |
19.9% |
You may also like the below Video Courses